Plasmanate (GRIFOLS USA, LLC)
Welcome to the PulseAid listing for the Plasmanate drug offered from GRIFOLS USA, LLC. This Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | GRIFOLS USA, LLC |
| NON-PROPRIETARY NAME: | Plasma Protein Fraction (Human) |
| SUBSTANCE NAME: | ALBUMIN HUMAN |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1958-10-02 |
| END MARKETING DATE: | 0000-00-00 |
Plasmanate PLASMA DERIVATIVE Details:
| Item Description | Plasmanate from GRIFOLS USA, LLC |
| LABELER NAME: | GRIFOLS USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(g/50mL) |
| START MARKETING DATE: | 1958-10-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 13533-613_21e1da7a-a24e-4949-8923-e70f6f490bf8 |
| PRODUCT NDC: | 13533-613 |
| APPLICATION NUMBER: | BLA101140 |
Other ALBUMIN HUMAN Pharmaceutical Manufacturers / Labelers:
